Fetal Anomalies Scan at the Time of Nuchal Translucency Study

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2009 by Sheba Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00943189
First received: July 21, 2009
Last updated: November 19, 2009
Last verified: November 2009
  Purpose

Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.


Condition
Fetal Anomalies

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Fetal Anomalies Scan at the Time of Nuchal Translucency Study

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 600
Study Start Date: June 2008
Detailed Description:

Prospective study of patients at 12-14 weeks gestation that are coming for NT examination is conducted. Meticulous ultrasound examination will be done to the fetuses using trans vaginal and transabdominal techniques. The patients will receive only the NT information. Only in cases of detection of severe fetal anomalies the patient will get the information of the examination and counseling according to the findings. All patients will be asked to provide information of the 15 weeks early comprehensive ultrasound examination. The NT examination will be compared to the 15 weeks ultrasound. All patients will be asked to give information after delivery of the baby's health condition.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

All pregnant women at 12-14 weeks of gestation that are coming for nuchal translucency examination and willing to participate in the study.

Criteria

Inclusion Criteria:

  • pregnant women at 12-14 weeks

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00943189

Contacts
Contact: Liat Gindes, MD gindesl@smile.net.il

Locations
Israel
Sheba Medical Center Recruiting
Ramat Gan, Israel
Contact: Liat Gindes, MD       gindesl@smile.net.il   
Sponsors and Collaborators
Sheba Medical Center
  More Information

No publications provided

Responsible Party: Dr. Liat Gindes, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00943189     History of Changes
Other Study ID Numbers: SHEBA-08-4934-LG-CTIL
Study First Received: July 21, 2009
Last Updated: November 19, 2009
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
Fetal anomalies scan at the time of NT study

Additional relevant MeSH terms:
Congenital Abnormalities

ClinicalTrials.gov processed this record on August 28, 2014